Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer

Immune checkpoint inhibitors have reshaped the prognostic of several tumor types, including metastatic colorectal tumors with microsatellite instability (MSI). However, 90-95% of metastatic colorectal tumors are microsatellite stable (MSS) in which immunotherapy has failed to demonstrate meaningful...

Descripción completa

Detalles Bibliográficos
Autores principales: Ros, Javier, Balconi, Francesca, Baraibar, Iosune, Saoudi Gonzalez, Nadia, Salva, Francesc, Tabernero, Josep, Elez, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932591/
https://www.ncbi.nlm.nih.gov/pubmed/36816981
http://dx.doi.org/10.3389/fonc.2023.1112276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932591/
https://www.ncbi.nlm.nih.gov/pubmed/36816981
http://dx.doi.org/10.3389/fonc.2023.1112276

Ejemplares similares